Analytical Data
-
Gene name
ARV1
- Application
-
Alternative Names
ARV1; HT035; Protein ARV1; hARV1
-
Species
Human
-
Source
E. coli
-
Tag
GST-tag at N-terminal
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q9H2C2
-
Expression Region
1-271aa
-
AA Sequence
MGNGGRSGLQQGKGNVDGVAATPTAASASCQYRCIECNQEAKELYRDYNHGVLKITICKSCQKPVDKYIEYDPVIILINAILCKAQAYRHILFNTQINIHGKLCIFCLLCEAYLRWWQLQDSNQNTAPDDLIRYAKEWDFYRMFAIAALEQTAYFIGIFTFLWVERPMTAKKKPNFILLLKALLLSSYGKLLLIPAVIWEHDYTSVCLKLIKVFVLTSNFQAIRVTLNINRKLSFLAVLSGLLLESIMVYFFQSMEWDVGSDYAIFKSQDF
-
Molecular Weight
57.5 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
ARV1 (Amplified RNA Virus 1) recombinant protein has garnered significant attention in recent years due to its potential applications in both therapeutic and diagnostic fields. The study of ARV1 is rooted in the growing understanding of viral mechanisms and host interactions, particularly in the context of viral pathogenesis and immune responses. ARV1 serves as a model for exploring how viruses manipulate host cellular machinery to replicate and spread, which can inform the development of antiviral strategies. Moreover, the recombinant protein allows researchers to investigate the structure-function relationship of viral proteins, facilitating the design of vaccines and therapeutics that can elicit robust immune responses. Additionally, ARV1's role in microbial resistance highlights the urgent need to develop novel approaches to combat viral infections, particularly in an era marked by rising antibiotic resistance and emerging viral pathogens. The elucidation of ARV1’s function and its interaction with host defenses may lead to innovative biotechnological applications and improve our understanding of viral ecology. As research progresses, the insights gained from ARV1 studies are expected to contribute to broader initiatives aimed at enhancing public health and developing effective countermeasures against viral outbreaks.
